Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: Implications for hematopoiesis, self-renewal and differentiation potential
- 30 March 2007
- journal article
- Published by Elsevier BV in Virology
- Vol. 360 (1), 6-16
- https://doi.org/10.1016/j.virol.2006.09.017
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblastsBiochemical and Biophysical Research Communications, 2005
- Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulationsBlood, 2004
- Downregulation of the cellular adhesion molecule Thy-1 (CD90) by cytomegalovirus infection of human fibroblastsJournal of General Virology, 2004
- Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In VitroThe International Journal of Cell Cloning, 2004
- Characterization and functionality of cell surface molecules on human mesenchymal stem cellsJournal of Biomedical Science, 2003
- Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cellsBlood, 2001
- Human Cytomegalovirus with IE-2 (UL122) Deleted Fails To Express Early Lytic GenesJournal of Virology, 2001
- The Role of Cytokines and Adhesion Molecules for Mobilization of Peripheral Blood Stem CellsThe International Journal of Cell Cloning, 2000
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cellsJournal of General Virology, 1991